Grown Rogue International (GRUSF) Cash & Equivalents Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Cash & Equivalents Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 29.96% |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 20.41% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -2.73% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.02% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 3.22% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 52.71% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 36.93% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 10.41% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 210.71% |
| Jul 31, 2023 | 120.68% |
| Apr 30, 2023 | 84.90% |
| Jan 31, 2023 | 127.92% |
| Oct 31, 2022 | -97.49% |
| Jan 31, 2022 | 27.94% |
| Oct 31, 2021 | 2.34% |
| Apr 30, 2021 | 51.18% |
| Oct 31, 2020 | -21.67% |
| Aug 31, 2018 | -4.34% |
| May 31, 2018 | 7,438.30% |
| Feb 28, 2018 | 6.37% |
| Nov 30, 2017 | -18.07% |
| Aug 31, 2017 | -79.62% |
| May 31, 2017 | -78.64% |
| Feb 28, 2017 | -48.90% |
| Nov 30, 2016 | 11.99% |
| Aug 31, 2016 | 22.26% |
| May 31, 2016 | -7.63% |
| Feb 29, 2016 | -61.96% |